FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and immunology. What is described is a recovered human antibody or its antigen-binding fragment. The antibody binds to human interleukin-4 alpha-receptor (hlL-4R). There are also described a nucleic acid molecule coding this antibody, an expression vector, a host cell, a method for producing such antibody and a therapeutic composition containing this antibody.
EFFECT: presented group of inventions can be used in medicine for treating asthma and atopic dermatitis.
15 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
HIGH-AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR | 2014 |
|
RU2663106C2 |
HIGH-AFFINITY HUMAN IL-4 RECEPTOR ANTIBODIES | 2007 |
|
RU2445318C2 |
ANTIBODIES OF HIGH AFFINITY TO IL-6-RECEPTOR OF HUMANS | 2007 |
|
RU2433138C2 |
HUMAN ANTIBODIES WITH HIGH AFFINITY TO HUMAN NERVE GROWTH FACTOR | 2008 |
|
RU2473564C2 |
HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | 2013 |
|
RU2628305C2 |
HUMAN ANTIBODIES TO DELTA-LIKE HUMAN LIGAND-4 | 2007 |
|
RU2448979C2 |
ANTIBODIES AGAINST HUMAN GDF8 | 2011 |
|
RU2567805C2 |
GDF8 HUMAN ANTIBODIES | 2011 |
|
RU2710156C2 |
HUMAN CD20 ANTIBODIES AND METHOD OF USING THEM | 2008 |
|
RU2486205C2 |
HIGH-AFFINITY HUMAN ANTI-PCSK9 ANTIBODIES | 2009 |
|
RU2552169C2 |
Authors
Dates
2015-01-27—Published
2009-10-27—Filed